PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-03-29

Date Title Company
29-Mar-2022 Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG Formycon AG
29-Mar-2022 Formycon and ATHOS KG merge development activities through the acquisition of biosimilar assets in a long-term strategic partnership Formycon AG
29-Mar-2022 Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration Rentschler Biopharma
29-Mar-2022 Teledyne Princeton Instruments announces new series of CCD cameras for Original Equipment Manufacturers Teledyne Princeton Instruments
29-Mar-2022 Qure.ai raises $40 Million from healthcare investors Novo Holdings and HealthQuad Qure.ai
29-Mar-2022 Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration B3C newswire
29-Mar-2022 Hansa Biopharma and Medison Pharma announce marketing authorization in Israel for Idefirix® (imlifidase) for desensitization treatment of highly sensitized kidney transplant patients Hansa Biopharma
29-Mar-2022 Freya Pharma Solutions secures US$8.5 million enabling the start of a pivotal phase 3 trial with Lybrido against Female Sexual Interest/Arousal Disorder (FSIAD) Freya Pharma Solutions
29-Mar-2022 OndexxyaÔÇ»approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors AstraZeneca
29-Mar-2022 eTheRNA Manufacturing Announces New LNP Formulation Development and Production Service eTheRNA Manufacturing
29-Mar-2022 Ebvia Announces Positive Results Published in Nature for TMPRSS2 Inhibitor for the Prevention and Treatment of COVID-19 Newswire
29-Mar-2022 Longwood Fund Announces Longwood Healthcare Leaders, a Web Conference for Industry Leaders, on May 4-5, 2022 Newswire
29-Mar-2022 Rejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth Rejuvenate Biomed
29-Mar-2022 Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy Santhera Pharmaceuticals
29-Mar-2022 Bone Therapeutics to strategically focus on lead cell therapy product ALLOB Bone Therapeutics
29-Mar-2022 Waiting in GP queues could be a thing of the past with 61% of people preferring to manage health at home Kinetik Wellbeing
29-Mar-2022 Neurovascular Stent Retrievers Market Covid-19 Impact Analysis, Opportunities, Threats, Drivers, Restraints, Trends, Applications, And Growth Forecast To 2026 MARKITWIRED
29-Mar-2022 Prenatal Vitamin Preparation Market Future Trends, Segmentation, Strategies to Boost Growth, Applications with Covid-19 Impact till 2026 MARKITWIRED
29-Mar-2022 Topical Antibiotic Pharmaceuticals Market Share, Top Operating Players, Recent Enhancements and Regional Analysis 2026 MARKITWIRED
29-Mar-2022 Anti-Neoplastic Pharmaceutical Agents Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2026 MARKITWIRED